Colin Green

Emeritus Professor Green holds the W&B Hadden Chair of Ophthalmology and Translational Vision Research at the University of Auckland, New Zealand. He has over 40 years of research experience including 12 years in France, United States (Baylor College of Medicine) and England (as a Royal Society Research Fellow and Reader, University College London). He has published >200 research manuscripts (including one in Science and two in Nature) and has an H index = 57. Dr. Green has supervised 60 postgraduate students to completion. Dr. Green’s own work has won the International Robert Feulgen Prize (1992), an Arthritis New Zealand Distinguished Service Award (2012), the Dame Ida Mann Lecture for Royal Australian and New Zealand College of Ophthalmologists (2012), the University of Auckland Vice-Chancellor's Commercialisation Medal (2014) and the Shorland Medal of the New Zealand Association of Scientists, 2017. His previous drug discovery, NEXAGON, a 'gap junction hemichannel modulator' for front-of-the-eye disorders is in final trials. Professor Green’s team is world leading on the role of gap junction channels in injury and disease, with new treatments for ocular and other diseases that go beyond the treatment of clinical signs to target underlying causes. His discoveries on connexin hemichannel roles in vascular dropout and perpetuation of the inflammasome pathway impact upon the understanding of many acute and chronic disease conditions. Dr. Green is an inventor on over 270 patents in thirty four patent families.